A detailed history of M28 Capital Management LP transactions in Silence Therapeutics PLC stock. As of the latest transaction made, M28 Capital Management LP holds 185,100 shares of SLN stock, worth $1.27 Million. This represents 3.2% of its overall portfolio holdings.

Number of Shares
185,100
Previous 185,100 -0.0%
Holding current value
$1.27 Million
Previous $3.52 Million 4.27%
% of portfolio
3.2%
Previous 4.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$18.31 - $23.91 $2.09 Million - $2.73 Million
-114,300 Reduced 38.18%
185,100 $3.52 Million
Q1 2024

May 14, 2024

SELL
$17.39 - $26.25 $1.12 Million - $1.69 Million
-64,400 Reduced 17.7%
299,400 $6.47 Million
Q2 2023

Aug 11, 2023

BUY
$4.61 - $7.44 $1 Million - $1.62 Million
217,900 Added 149.35%
363,800 $2 Million
Q4 2022

Feb 10, 2023

BUY
$9.69 - $17.09 $1.41 Million - $2.49 Million
145,900 New
145,900 $2.22 Million

Others Institutions Holding SLN

About Silence Therapeutics plc


  • Ticker SLN
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,888,400
  • Market Cap $247M
  • Description
  • Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...
More about SLN
Track This Portfolio

Track M28 Capital Management LP Portfolio

Follow M28 Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M28 Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on M28 Capital Management LP with notifications on news.